Page last updated: 2024-10-27

gbr 12935 and Mitochondrial Diseases

gbr 12935 has been researched along with Mitochondrial Diseases in 1 studies

1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battaglia, G1
Farrace, MG1
Mastroberardino, PG1
Viti, I1
Fimia, GM1
Van Beeumen, J1
Devreese, B1
Melino, G1
Molinaro, G1
Busceti, CL1
Biagioni, F1
Nicoletti, F1
Piacentini, M1

Other Studies

1 other study available for gbr 12935 and Mitochondrial Diseases

ArticleYear
Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.
    Journal of neurochemistry, 2007, Volume: 100, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Basal Ganglia Disease

2007